313 related articles for article (PubMed ID: 25883030)
1. Surface modification and local orientations of surface molecules in nanotherapeutics.
Amin ML; Joo JY; Yi DK; An SS
J Control Release; 2015 Jun; 207():131-42. PubMed ID: 25883030
[TBL] [Abstract][Full Text] [Related]
2. Recent Developments in the Application of Polymeric Nanoparticles as Drug Carriers.
Moritz M; Geszke-Moritz M
Adv Clin Exp Med; 2015; 24(5):749-58. PubMed ID: 26768624
[TBL] [Abstract][Full Text] [Related]
3. Cell membrane-camouflaged nanoparticles for drug delivery.
Luk BT; Zhang L
J Control Release; 2015 Dec; 220(Pt B):600-7. PubMed ID: 26210440
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-responsive polymeric nanoparticles for nanomedicine.
Crucho CI
ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
[TBL] [Abstract][Full Text] [Related]
5. Preparation and Surface Modification of Polymeric Nanoparticles for Drug Delivery: State of the Art.
Joshi G; Patel M; Chaudhary D; Sawant K
Recent Pat Drug Deliv Formul; 2020; 14(3):201-213. PubMed ID: 32885767
[TBL] [Abstract][Full Text] [Related]
6. New views and insights into intracellular trafficking of drug-delivery systems by fluorescence fluctuation spectroscopy.
Coppola S; Caracciolo G
Ther Deliv; 2014 Feb; 5(2):173-88. PubMed ID: 24483195
[TBL] [Abstract][Full Text] [Related]
7. Effect of the surface modification, size, and shape on cellular uptake of nanoparticles.
Salatin S; Maleki Dizaj S; Yari Khosroushahi A
Cell Biol Int; 2015 Aug; 39(8):881-90. PubMed ID: 25790433
[TBL] [Abstract][Full Text] [Related]
8. Theranostic nanoparticles engineered for clinic and pharmaceutics.
Ma X; Zhao Y; Liang XJ
Acc Chem Res; 2011 Oct; 44(10):1114-22. PubMed ID: 21732606
[TBL] [Abstract][Full Text] [Related]
9. Factors affecting toxicity and efficacy of polymeric nanomedicines.
Igarashi E
Toxicol Appl Pharmacol; 2008 May; 229(1):121-34. PubMed ID: 18355886
[TBL] [Abstract][Full Text] [Related]
10. Insight into nanoparticle cellular uptake and intracellular targeting.
Yameen B; Choi WI; Vilos C; Swami A; Shi J; Farokhzad OC
J Control Release; 2014 Sep; 190():485-99. PubMed ID: 24984011
[TBL] [Abstract][Full Text] [Related]
11. Toward therapeutic delivery with layer-by-layer engineered particles.
Yan Y; Such GK; Johnston AP; Lomas H; Caruso F
ACS Nano; 2011 Jun; 5(6):4252-7. PubMed ID: 21612259
[TBL] [Abstract][Full Text] [Related]
12. Ocular drug delivery: nanomedicine applications.
Vandervoort J; Ludwig A
Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic applications of electrospun nanofibers for drug delivery systems.
Son YJ; Kim WJ; Yoo HS
Arch Pharm Res; 2014 Jan; 37(1):69-78. PubMed ID: 24234913
[TBL] [Abstract][Full Text] [Related]
14. Functionalized gold nanoparticles for drug delivery.
Han G; Ghosh P; Rotello VM
Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
[TBL] [Abstract][Full Text] [Related]
15. Coating nanoparticles with cell membranes for targeted drug delivery.
Gao W; Zhang L
J Drug Target; 2015; 23(7-8):619-26. PubMed ID: 26453159
[TBL] [Abstract][Full Text] [Related]
16. Availability of polymeric nanoparticles for specific enhanced and targeted drug delivery.
Kiriyama A; Iga K; Shibata N
Ther Deliv; 2013 Oct; 4(10):1261-78. PubMed ID: 24116911
[TBL] [Abstract][Full Text] [Related]
17. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
[TBL] [Abstract][Full Text] [Related]
18. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: current status.
van der Meel R; Vehmeijer LJ; Kok RJ; Storm G; van Gaal EV
Adv Drug Deliv Rev; 2013 Oct; 65(10):1284-98. PubMed ID: 24018362
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters.
Gaumet M; Vargas A; Gurny R; Delie F
Eur J Pharm Biopharm; 2008 May; 69(1):1-9. PubMed ID: 17826969
[TBL] [Abstract][Full Text] [Related]
20. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
GuhaSarkar S; Banerjee R
J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
